On the recordJanuary 31, 2012
The reauthorization of the FDA user fee program presents Congress with the opportunity to improve upon the current U.S. drug and device approval pathway.
Source
congress.govPhil Gingrey: “The reauthorization of the FDA user fee program presents Congress with the opportunity to improve upon the current U.S.…”
Editor's note · Context
Gingrey emphasizes the chance to enhance drug approval processes through reauthorization.
Share
More from Phil Gingrey
Apr 10, 2013
I don't think that anyone here would disagree that the Medicare program of today is in trouble.
Jun 11, 2014
All of these mandates, all this mandated coverage, comes at a tremendous price.
Mar 14, 2013
If our goal was to improve the rate of individuals who have insurance in this country, why on Earth would we deliberately make it more expensive to obtain?
Nov 19, 2013
As educators and legislators, we must not neglect our duties to equip these young people, our children, these students, with the tools and the knowledge to build a successful career.
Other voices in this conversation
